Urihk Pharmaceutical hosted a webinar on the topic- Immunomodulators in critical illness under our owned forum of advocacy in Immune Modulation in critically ill patients (AIMC) which held on 12 June 2021

 As part of our ongoing health initiative, we at Urihk Pharmaceuticals hosted a webinar in our Immune Modulation in critically ill patients (AIMC) forum. AIMC is a forum for the exchange of ideas and scientific discussion on immune regulation in critical illness.

The event was moderated by Dr. P B N Gopal, Senior Consultant & Head, Department of Critical Care Medicine, Continental Hospital, Hyderabad.

Many Healthcare professionals across Telangana & Karnataka participated in the webinar, with the orchestration of leaders –

 Dr. Raghavendra Reddy, Pulmonologist, Renova Neelima Hospitals, Hyderabad, and Dr. Ravi Kumar, HOD ICU at Sagar Group of Hospitals, Bangalore who meticulously talked about Immune Dysregulation and Therapeutic Approach: Sepsis and ARDS and Covid 19.

The event was followed by a panel discussion. Among the various immunomodulators, which one is recommended and why? Immunomodulator and Application during Covid 19? What are the recent developments in this area? How can we make our patients better? All these questions were answered at the panel discussion by Eminent Faculty – Dr. Jyoti V Hattiholi, Associate Professor, J N Medical College, Belgaum. Dr. Huzefa Suratwala Ismail, Consultant, Medfine Clinic, Bangalore, Dr. Debasish Barik Consultant, Best E-City Hospital, Bangalore.